Large-scale sequencing projects have revealed several potential AML driver genes, including NPM1, CEBPA, DNMT3A, TET2, RUNX1, ASXL1, IDH2, and MLL, and have identified critical mutations in FLT3, IDH1, KIT, and RAS. This evidence concerns the gene DNMT3A and acute myeloid leukemia.